Sign in
Taking people in United StatesNo phase

Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis

Key facts

Who runs it
University of Utah
Where
Los Angeles and Salt Lake City, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
110 people, planned
Started
21 Oct 2025
Expected to end
31 Mar 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Decision support tool
Record updated
10 August 2026

Who can take part

Age
8 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Parent-child dyads of children with neuromuscular scoliosis who speak English and Spanish
  • Child is between ages 8-21 years of age and they are coming into the pediatric orthopaedic surgery clinic for consultation about potential surgery for NMS
  • NMS is defined as having neurologic impairment (NI) and scoliosis using relevant ICD-9 or ICD-10 codes from Feudtner, et al. 2014 or Berry, et al. 2012. or a qualifying diagnosis per the Pediatric Spine Study Group definition of NMS
  • All pediatric orthopaedic surgeons and neurosurgeons who treat neuromuscular scoliosis at our study sites will be eligible participants

Who cannot take part

  • Children with the diagnosis of Becker's muscular dystrophy due to potential disease modifying therapies that may alter curve progression
  • Families whose child with NMS is less than 8 years of age at time of orthopaedic consultation because surgery at a younger age usually indicates an atypical case

Where in United States

  • Children's Hospital Los AngelesLos Angeles, United StatesContact: Amberly ThaiTaking people
  • University of UtahSalt Lake City, United StatesContact: Angela ZhuTaking people

About the trial

What the trial wants to find out

The goal of this pilot hybrid type I efficacy/implementation trial is to assess a newly developed decision support tool patients, parents, and providers to use during surgical treatment decision making for neuromuscular scoliosis (NMS). Results from this pilot will inform the design of a future larger effectiveness trial of the decision support tool.

Read full original descriptionShow less

Participants will either receive usual care or receive the decision support tool. Researchers will assess the decision made, decision quality, individual affective, cognitive, and behavioral effects, and feasibility and acceptability of tool use. They will also collect potential barriers and facilitators to implementation and feedback about the tool and study design to maximize likelihood of successful deployment of the tool into clinical practice and inform the design of a future trial. The outcomes measures will be used to inform potential effect size estimates to inform a future trial.

The 2 groups in the trial

  • Usual careNo study treatment, for comparison

    Participants receive usual care

  • Decision support toolTreatment being tested

    Participants receive the novel decision support tool

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis - Aims 2 and 3
Record updated
10 August 2026